AVERSA, ROBERT JOHN,BURGER, MATTHEW T.,DILLON, MICHAEL PATRICK,DINEEN, THOMAS A., JR.,KARKI, RAJESH,RAMURTHY, SAVITHRI,RAUNIYAR, VIVEK,ROBINSON, RICHARD,SARVER, PATRICK JAMES
申请号：
CA3008098
公开号：
CA3008098A1
申请日:
2016.12.15
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention provides compounds of Formula (A): (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent, and methods of using the compositions and combinations to treat conditions including cancers.
